SBC Medical Group (NASDAQ:SBC) Shares Up 16.2% - Here's Why

Key Points

• SBC Medical Group's stock rose by 16.2% on Monday, trading at a high of $4.86 compared to its previous close of $4.15.
• Analysts at Wall Street Zen have downgraded SBC Medical Group shares from a "buy" rating to a "hold" rating.
• The company reported $0.02 earnings per share for the last quarter, falling short of expectations by $0.12, and had a revenue of $43.36 million against the forecast of $44.71 million.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report)'s share price shot up 16.2% during trading on Monday . The company traded as high as $4.86 and last traded at $4.82. 75,211 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 65,225 shares. The stock had previously closed at $4.15.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of SBC Medical Group from a "buy" rating to a "hold" rating in a report on Friday, September 5th.

SBC Medical Group Stock Down 0.2%

The company has a current ratio of 3.98, a quick ratio of 3.95 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $465.39 million, a price-to-earnings ratio of 14.00 and a beta of 1.27. The firm's 50 day simple moving average is $4.53 and its 200-day simple moving average is $4.14.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.12). The firm had revenue of $43.36 million during the quarter, compared to analyst estimates of $44.71 million. SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. On average, sell-side analysts anticipate that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current fiscal year.

Hedge Funds Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently made changes to their positions in SBC. SBI Securities Co. Ltd. grew its stake in shares of SBC Medical Group by 227.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after purchasing an additional 37,623 shares during the period. Geode Capital Management LLC purchased a new stake in shares of SBC Medical Group in the 2nd quarter worth about $455,000. XTX Topco Ltd purchased a new stake in shares of SBC Medical Group in the 2nd quarter worth about $64,000. Finally, New York State Common Retirement Fund purchased a new stake in shares of SBC Medical Group in the 2nd quarter worth about $104,000. 60.82% of the stock is owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.